Paul Warrener

10.2k total citations · 3 hit papers
42 papers, 4.2k citations indexed

About

Paul Warrener is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Paul Warrener has authored 42 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Infectious Diseases and 9 papers in Molecular Medicine. Recurrent topics in Paul Warrener's work include Bacterial biofilms and quorum sensing (11 papers), Antibiotic Resistance in Bacteria (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Paul Warrener is often cited by papers focused on Bacterial biofilms and quorum sensing (11 papers), Antibiotic Resistance in Bacteria (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Paul Warrener collaborates with scholars based in United States, Canada and United Kingdom. Paul Warrener's co-authors include Marc S. Collett, C. Kendall Stover, Donald R. VanDevanter, James Tamura, Leonard L. Bennett, Sally Coulter, Timothy M. Rose, Emily R. Schultz, Richard L. Garber and David R. Sherman and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Paul Warrener

41 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

2000 796 citations C. Kendall Stover, Paul Warrener et al. Nature profile →
Detection and analysis of diverse herpesviral species by consensus primer PCR

1996 645 citations Donald R. VanDevanter, Paul Warrener et al. profile →
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes

1993 264 citations JoAnn Suzich, Paul Warrener et al. profile →

Peers

Countries citing papers authored by Paul Warrener

Since Specialization

Citations

This map shows the geographic impact of Paul Warrener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Warrener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Warrener more than expected).

Fields of papers citing papers by Paul Warrener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Warrener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Warrener. The network helps show where Paul Warrener may publish in the future.

Co-authorship network of co-authors of Paul Warrener

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Warrener. A scholar is included among the top collaborators of Paul Warrener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Warrener. Paul Warrener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure of ClfA002 in Complex With Neutralizing Antibody AZD7745 Provides Insight into Its Broad Neutralization Mechanism in Staphylococcus aureus Infection 2025 ·The Journal of Infectious Diseases ·Christine Tkaczyk, Tal Keren‐Kaplan, (unknown), Paul Warrener, Е. А. Семенова, (unknown), Arnita Barnes, (unknown), Bret R. Sellman, Ondřej Podlaha, Vaheh Oganesyan	0
2	A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis 2024 ·American Journal of Respiratory and Critical Care Medicine ·Merete Long, (unknown), (unknown), David E. Tabor, Ashley Keller, Paul Warrener, Vancheswaran Gopalakrishnan, Sanna Rosengren, Megan Crichton, (unknown), Yan Hui Giam, Holly R. Keir, (unknown), Rod Hughes, Maria G. Belvisi, Bret R. Sellman, (unknown), James D. Chalmers	10
3	Phenotypic whole-cell screening identifies a protective carbohydrate epitope on Klebsiella pneumoniae 2021 ·mAbs ·(unknown), (unknown), (unknown), (unknown), Josefin Bartholdson Scott, David E. Tabor, Gordon Dougan, Graham Christie, Paul Warrener, Ralph Minter, Andrew J. Grant	10
4	Neutrophil Extracellular Traps Confine Pseudomonas aeruginosa Ocular Biofilms and Restrict Brain Invasion 2019 ·Cell Host & Microbe ·Ajitha Thanabalasuriar, (unknown), Moritz Peiseler, (unknown), Zhutian Zeng, Paul Warrener, Ashley Keller, (unknown), E. Ashley Dozier, (unknown), Lily Cheng, Mihaela Gadjeva, C. Kendall Stover, Antonio DiGiandomenico, Paul Kubes	147
5	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 2019 ·World Journal of Gastroenterology ·Michelle L. Boland, Denise Oró, K.S. Tølbøl, (unknown), Jens Christian Nielsen, Taylor S. Cohen, David E. Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne Skovgård Veidal, Paul Warrener, Bret R. Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L. Trevaskis, Henrik H. Hansen	83
6	Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus aureus Fitness in Infection Models 2018 ·Antimicrobial Agents and Chemotherapy ·Christine Tkaczyk, Е. А. Семенова, Yuru Shi, (unknown), Vaheh Oganesyan, Paul Warrener, (unknown), Bret R. Sellman	17
7	The Neutrophilic Response to Pseudomonas Damages the Airway Barrier, Promoting Infection by Klebsiella pneumoniae 2018 ·American Journal of Respiratory Cell and Molecular Biology ·Omari Jones-Nelson, Jamese J. Hilliard, Antonio DiGiandomenico, Paul Warrener, (unknown), Lily Cheng, C. Kendall Stover, Taylor S. Cohen, Bret R. Sellman	12
8	Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4 2017 ·JCI Insight ·Taylor S. Cohen, Mark Pelletier, Lily Cheng, Meghan E. Pennini, Jessica Bonnell, (unknown), (unknown), Xiaodong Xiao, Elisabetta Cameroni, Davide Corti, Е. А. Семенова, Paul Warrener, Bret R. Sellman, JoAnn Suzich, Qun Wang, C. Kendall Stover	36
9	Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface 2017 ·Journal of Biological Chemistry ·Heather K. Kroh, Ramyavardhanee Chandrasekaran, (unknown), Rob Woods, Xiaofang Jin, Melanie D. Ohi, Andrew C. Nyborg, G. Jonah Rainey, Paul Warrener, Benjamin W. Spiller, D. Borden Lacy	10
10	Pseudomonas aeruginosaBacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide 2015 ·The Journal of Infectious Diseases ·Joshua T. Thaden, Ashley Keller, Norah J. Shire, (unknown), Linda G. Otterson, Michael D. Huband, Caitlin M. Guenther, Zhao Wei, Paul Warrener, C. Kendall Stover, Vance G. Fowler, Antonio DiGiandomenico	19
11	A multifunctional bispecific antibody protects against Pseudomonas aeruginosa 2014 ·Science Translational Medicine ·Antonio DiGiandomenico, Ashley Keller, Cuihua Gao, G. Jonah Rainey, Paul Warrener, (unknown), Jessica Bonnell, Ryan Fleming, Binyam Bezabeh, Nazzareno Dimasi, Bret R. Sellman, Jamese J. Hilliard, Caitlin M. Guenther, Vivekananda Datta, Zhao Wei, Changshou Gao, Xiang‐Qing Yu, JoAnn Suzich, C. Kendall Stover	215
12	Fatty Aldehydes in Cyanobacteria Are a Metabolically Flexible Precursor for a Diversity of Biofuel Products 2013 ·PLoS ONE ·Brett K. Kaiser, Michael Carleton, Jason W. Hickman, (unknown), David Lawson, Mark W. Budde, Paul Warrener, Angel Paredes, Srinivas Mullapudi, (unknown), Fred Cross, James M. Roberts	53
13	Glycogen synthesis is a required component of the nitrogen stress response in Synechococcus elongatus PCC 7942 2013 ·Algal Research ·Jason W. Hickman, (unknown), (unknown), Paul Warrener, Brett K. Kaiser, (unknown), Mark W. Budde, Fred Cross, James M. Roberts, Michael Carleton	61
14	Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ 2012 ·APOPTOSIS ·Paul Warrener, (unknown), Sybil M. Genther Williams, Matthew C. Biery, (unknown), Carlo Toniatti, Michele A. Cleary, Peter S. Linsley, Michael Carleton	7
15	Identification of broadly protective human antibodies toPseudomonas aeruginosaexopolysaccharide Psl by phenotypic screening 2012 ·The Journal of Experimental Medicine ·Antonio DiGiandomenico, Paul Warrener, Melissa Hamilton, Sandrine Guillard, Peter Ravn, Ralph Minter, (unknown), (unknown), Randall S. MacGill, (unknown), Qun Wang, Ashley Keller, Jessica Bonnell, Mladen Tomich, Lutz Jermutus, M. McCarthy, David Melnick, JoAnn Suzich, C. Kendall Stover	133
16	Identification of SULF2 as a Novel Transcriptional Target of p53 by Use of Integrated Genomic Analyses 2009 ·Cancer Research ·B. Nelson Chau, Robert L. Diaz, Matthew A. Saunders, Chun Cheng, Aaron N. Chang, Paul Warrener, Jeffrey D. Bradshaw, Peter S. Linsley, Michele A. Cleary	42
17	RNA Interference-Mediated Silencing of Mitotic Kinesin KIF14 Disrupts Cell Cycle Progression and Induces Cytokinesis Failure 2006 ·Molecular and Cellular Biology ·Michael Carleton, Mao Mao, Matthew C. Biery, Paul Warrener, (unknown), Carolyn A. Buser, C. Gary Marshall, Christine Fernandes, James Annis, Peter S. Linsley	100
18	A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis breakdown → 2000 ·Nature ·C. Kendall Stover, Paul Warrener, Donald R. VanDevanter, David R. Sherman, T M Arain, (unknown), (unknown), (unknown), Ying Yuan, David N. McMurray, Barry N. Kreiswirth, Clifton E. Barry, William R. Baker	796
19	Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. 1992 ·Journal of Clinical Investigation ·Stephen J. Rosenfeld, Kohji Yoshimoto, Sachiko Kajigaya, Sarah N. Anderson, Neal S. Young, A. M. Field, Paul Warrener, Geetha P. Bansal, Marc S. Collett	87
20	Phosphorylation and proteolytic degradation of nucleolin from 3T3-F442A cells 1991 ·Biochemical and Biophysical Research Communications ·Paul Warrener, (unknown)	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact